SPH Notification for a significant shareholding from CUPF Alianz Bulgaria
Sofia, Bulgaria, January 31, 2025 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD (SFA: “Bulgarian Stock Exchange AD, SPH: Warsaw Stock Exchange) notifies that today the Company received a notification for significant shareholding from CUPF Alianz Bulgaria. As a result of the conditional capital increase through exercising warrants from issue BG9200001212, the total shareholding of the pension funds managed by the Allianz Bulgaria Investment Fund CUPF "Allianz Bulgaria", ZPPF "Allianz Bulgaria" and DPF "Allianz Bulgaria" passively passes below the threshold of 5% in the capital of "Sopharma" AD and reaches 4.9869%.
| Data | Tytuł | Kurs | Zmiana |
|---|
2025-02-20 | SPH Sales revenues for January 2025 | 12,50 | 0,00 |
2025-02-07 | SPH Minutes of the Extraordinary Generam Meeting of Shareholders of "Sopharma" AD, held on February 7, 2025 | 12,30 | +0,41 |
2025-01-31 | SPH Notification for a significant shareholding from CUPF Alianz Bulgaria | 12,60 | 0,00 |
2025-01-30 | SPH Individual financial report according to IFRS as of 31 December 2024 | 13,10 | -3,82 |
2025-01-28 | SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for receival of shares from the capital increase of Sopharma AD | 12,50 | 0,00 |
2025-01-20 | SPH Sales revenues for December 2024 | 12,50 | +8,40 |
2025-01-15 | SPH Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212 | 13,75 | -1,09 |
2025-01-02 | SPH Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 27 December 2024 | 12,25 | 0,00 |
2025-01-02 | SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 27 December 2024 | 12,25 | 0,00 |
2024-12-23 | SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD | 12,25 | 0,00 |
